Abstract
We describe the updated Korean Society of Gynecologic Oncology (KSGO) practice guideline for the management of cervical cancer, version 5.1. The KSGO announced the fifth version of its clinical practice guidelines for the management of cervical cancer in March 2024. The selection of the key questions and the systematic reviews were based on data available up to December 2022. Between 2023 and 2024, substantial findings from large-scale clinical trials and new advancements in cervical cancer research remarkably emerged. Therefore, based on the existing version 5.0, we updated the guidelines with newly accumulated clinical data and added 4 new key questions reflecting the latest insights in the field of cervical cancer. For each question, recommendation was formulated with corresponding level of evidence and grade of recommendation, all established through expert consensus.
| Original language | English |
|---|---|
| Article number | e70 |
| Journal | Journal of Gynecologic Oncology |
| Volume | 36 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2025 |
Bibliographical note
Publisher Copyright:© 2025. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Chemoradiotherapy
- Immune Checkpoint Inhibitors
- Minimally Invasive Surgical Procedures
- Practice Guideline
- Uterine Cervical Neoplasms
Fingerprint
Dive into the research topics of 'Clinical practice guidelines for cervical cancer: an update of the Korean Society of Gynecologic Oncology Guidelines'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver